Advertisement

Topics

New Post-Hoc Analysis Evaluating Deep Remission with Entyvio® (vedolizumab) in Patients with ...

13:30 EST 9 Nov 2017 | BioMedReports - Blog

As treatment options become available for inflammatory bowel disease (IBD), treatment goals are evolving beyond the control of symptoms toward control of objectively-measured gastrointestinal inflammation.

Read more...

Original Article: New Post-Hoc Analysis Evaluating Deep Remission with Entyvio® (vedolizumab) in Patients with ...

NEXT ARTICLE

More From BioPortfolio on "New Post-Hoc Analysis Evaluating Deep Remission with Entyvio® (vedolizumab) in Patients with ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...